BioSpace News Archive

Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce today that it closed its previously announced registered direct offering for the purchase and sale of 7,000,000 common shares of the Company (the “Common Shares”) at a purchase price of US$0.17

PCT LTD (OTC Pink: PCTL) (“PCTL”) is pleased to announce that it has received approval for “emerging pathogens” labeling with the US EPA.

Forward Science, a local Houston MedTech company, begins making hand sanitizer to support local Texas hospital demand

Cerner Corporation, a global health care technology company, continues to support health systems around the world as they fight the COVID-19 pandemic.

March 27, 2020 18:00 UTC Anthem Medical Associate Volunteer Program Allows Employees to Volunteer and Support Care Delivery in their Community INDIANAPOLIS--( BUSINESS WIRE )-- As part of Anthem’s commitment to helping address the COVID-19 crisis, today the company announced simplified policies designed to help providers deliver care to patients more quickly and effectively. Today, unless otherwise required under specific State and Federal mandates, Anthem health plans wi

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it closed its previously announced registered direct offering for the purchase and sale of 1,000,002 shares of the Company’s common stock,

ProBioGen AG today announced that Immunogenesis, Inc., a spin-off of the MD Anderson Cancer Center, University of Texas, has signed a Service Agreement for Cell Line Development, Process Development and GMP Manufacturing in 1,000 L bioreactor scale for their lead candidate in the field of Immuno-Oncology.

As COVID-19 places a strain on urgent patient care and therapeutic treatments, a critical need has developed for medical supplies that are indispensable on the front line. To address this crucial need, LifeSciences BC has taken on the role of identifying, creating and collecting medical equipment to enable dispensing of vital patient care treatment without interruption.

Today, Praesidio Life Sciences announced it will service health systems and state agencies across the country by providing one-step antibody screening tests for COVID-19.

Data submitted to the TFDA show an ORR of 84% with most adverse events (AEs) reported as Grade 1 or 2 for avapritinib in patients with advanced GIST harboring a PDGFRA exon 18 mutation, including PDGFRA D842V mutations